press release transmitted on behalf of: Asklepios Kliniken GmbH & Co. KGaA. In case of any questions, please contact the issuer directly. Please do not reply to this e-mail.
****** Nominations for the Broermann Medical Innovation Award 2026 now open
– With a million euros, it is one of the world’s most highly endowed awards for medical research
The nomination period for the Broermann Medical Innovation Award (www.broermann-award.org/) 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made pioneering contributions in medicine, biotechnology, or related fields may be nominated. The nomination portal (www.broermann-award.org/nomination/) will remain open until March 1, 2026.
The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026.
Debut of the Broermann Medical Innovation Award This Year
The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden.
About the Award
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinnützige GmbH and organized through the University Hospital Gießen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder’s firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.
Further information about the award, nomination criteria, and selection process can be found on the award website (www.broermann-award.org) .
Contact: Broermann Medical Innovation Award Contact: Mirjam Malko Tel.: +49 (0) 641 / 985-42310 E-Mail: mailto:contact@broermann-award.org
Asklepios Kliniken Konzernbereich Unternehmenskommunikation & Marketing Tel.: +49 (0) 40 / 18 18-82 66 36 E-Mail: mailto:presse@asklepios.com 24-hour press office hotline: +49 (0) 40 / 1818-82 8888
Visit Asklepios on the Internet and Social Media: www.asklepios.com www.asklepios.com/gesundheitsmagazin www.youtube.com/asklepioskliniken de.linkedin.com/company/asklepios www.instagram.com/asklepioskliniken/ www.facebook.com/asklepioskliniken
****** Nominations for the Broermann Medical Innovation Award 2026 now open
– With a million euros, it is one of the world’s most highly endowed awards for medical research
The nomination period for the Broermann Medical Innovation Award (www.broermann-award.org/) 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made pioneering contributions in medicine, biotechnology, or related fields may be nominated. The nomination portal (www.broermann-award.org/nomination/) will remain open until March 1, 2026.
The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026.
Debut of the Broermann Medical Innovation Award This Year
The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden.
About the Award
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinnützige GmbH and organized through the University Hospital Gießen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder’s firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.
Further information about the award, nomination criteria, and selection process can be found on the award website (www.broermann-award.org) .
Contact: Broermann Medical Innovation Award Contact: Mirjam Malko Tel.: +49 (0) 641 / 985-42310 E-Mail: mailto:contact@broermann-award.org
Asklepios Kliniken Konzernbereich Unternehmenskommunikation & Marketing Tel.: +49 (0) 40 / 18 18-82 66 36 E-Mail: mailto:presse@asklepios.com 24-hour press office hotline: +49 (0) 40 / 1818-82 8888
Visit Asklepios on the Internet and Social Media: www.asklepios.com www.asklepios.com/gesundheitsmagazin www.youtube.com/asklepioskliniken de.linkedin.com/company/asklepios www.instagram.com/asklepioskliniken/ www.facebook.com/asklepioskliniken
****** This e-mail was sent to you by news aktuell GmbH on behalf of the issuer. The issuer / sender referred to in the “From” section is solely responsible for the content of this release.
To unsubscribe from these emails, click here: newsaktuell.de/unsub/35589344-75306263f3d3390054e0cca1973d8bba
news aktuell GmbH – Ein Unternehmen der dpa-Gruppe Mittelweg 144, 20148 Hamburg Telefon: +49 (0)40 4113-32850, Telefax: +49 (0)40 4113-32855 www.newsaktuell.de
Registergericht: Hamburg, Registernummer: HRB 127245 Umsatzsteuer-Identifikationsnummer gemäß § 27 a Umsatzsteuergesetz: DE815240626 Vertretungsberechtigte Personen: Petra Busch (Geschäftsführerin), Vithunan Lingeswaran (Geschäftsführer)
